13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-12, with 31 holding rows worth $384,916,993.
- Accession
- 0000950123-23-004668
- Filer
- CIK 1687078
- Filed
- 2023-05-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 31 entries on the cover page, a total value of $384,916,993 stated on the cover page (in dollars after the unit check, H1), rows summing to $384,916,993 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $78,241,782 | dollars as filed | |
| PROVENTION BIO INC | 74374N102 | COM | 1,173,809 | $28,288,797 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 1,045,691 | $25,441,662 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,745,943 | $23,762,284 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 1,192,281 | $22,498,342 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 572,459 | $21,335,547 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,225,634 | $20,186,192 | dollars as filed | |
| GERON CORP | 374163103 | COM | 8,401,565 | $18,231,396 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 176,874 | $16,544,794 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,639,849 | $16,136,114 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 2,614,977 | $15,977,509 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 617,671 | $11,680,159 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 803,501 | $11,586,484 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 36,038 | $8,730,566 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 313,642 | $7,053,809 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 348,224 | $7,013,231 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 399,192 | $6,806,224 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,388,011 | $6,208,829 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 360,392 | $5,787,896 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 247,022 | $5,350,497 | dollars as filed | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 3,370,982 | $5,056,473 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 197,806 | $4,579,209 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 70,402 | $4,342,395 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 388,292 | $4,306,158 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 254,137 | $2,795,507 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 3,196,707 | $2,378,350 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 212,615 | $1,518,071 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 233,728 | $1,339,261 | dollars as filed | |
| ONCORUS INC | 68236R103 | COM | 2,377,031 | $817,699 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 647,918 | $647,918 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 144,888 | $273,838 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-004668 | this filing | 2023-05-12 | acceptance time not in the bulk data set |